PD-L2 is expressed on activated human T cells and regulates their function

被引:98
|
作者
Messal, Nassima [1 ,2 ,3 ]
Serriari, Nacer-Eddine [1 ,2 ,3 ]
Pastor, Sonia [1 ,2 ,3 ]
Nunes, Jacques A. [1 ,2 ,3 ]
Olive, Daniel [1 ,2 ,3 ]
机构
[1] Ctr Rech Cancerol Marseille, Inst Natl Sante & Rech Med, U891, F-13009 Marseille, France
[2] Inst J Paoli I Calmettes, F-13009 Marseille, France
[3] Univ Mediterranee, F-13009 Marseille, France
关键词
T cells; Cell activation; Costimulatory molecules; PD-L2; B7; LIGANDS; SUSCEPTIBILITY; INFECTION; RESPONSES;
D O I
10.1016/j.molimm.2011.06.436
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
T-cell activation and proliferation are regulated by cosignaling adhesion molecules involved in positive or negative signals. Programmed death (PD)-1 is one of immune inhibitory molecules that is expressed in activated T cells and is a promising target for immunotherapy. Both PD-1 ligands, PD-L1 and PD-L2 are expressed on antigen presenting cells (APCs) involved in the dialogue between a T cell and an APC. Here, we analysed the expression of these ligands, especially for PD-L2, on T cells. PD-L2 appears to be expressed on activated CD4 and CD8T cell subsets. Moreover, as PD-1 molecule, PD-L2 engagement at the surface of T cells is able to down-modulate cytokine production and cell proliferation. These observations indicate that PD-L2 is expressed following activation and is involved in the regulation of T cell function, highlighting the level of complexity in the T cell cosignaling network. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2214 / 2219
页数:6
相关论文
共 50 条
  • [21] Association of PD-L2 expression in human tumors with atezolizumab activity
    Schulz, C.
    Schmid, P.
    Hedge, P.
    Zou, W.
    Kowanetz, M.
    Mariathasan, S.
    Gadgeel, S.
    Powles, T.
    Van Der Heijden, M. S.
    Fasso, M.
    O'Hear, C.
    Ballinger, M.
    Fine, G.
    Sandler, A.
    Chen, D.
    Hodi, S. F.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 134 - 134
  • [22] PD-L2 is a second ligand for PD-I and inhibits T cell activation
    Latchman, Y
    Wood, CR
    Chernova, T
    Chaudhary, D
    Borde, M
    Chernova, I
    Iwai, Y
    Long, AJ
    Brown, JA
    Nunes, R
    Greenfield, EA
    Bourque, K
    Boussiotis, VA
    Carter, LL
    Carreno, BM
    Malenkovich, N
    Nishimura, H
    Okazaki, T
    Honjo, T
    Sharpe, AH
    Freeman, GJ
    NATURE IMMUNOLOGY, 2001, 2 (03) : 261 - 268
  • [23] PD-L2 Elbows out PD-L1 to Rescue T Cell Immunity to Malaria
    Crompton, Peter D.
    Pierce, Susan K.
    IMMUNITY, 2016, 45 (02) : 231 - 233
  • [24] Choline acetyltransferase is expressed by activated human T cells
    Tarnawski, Laura
    Admassu, Henok
    Olofsson, Peder S.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 279 - 280
  • [25] VISTA expressed in tumor cells regulates T cell function
    Murat, Kumuruz
    Hamanishi, Junzo
    Matsumura, Noriomi
    Chamoto, Kenji
    Mise, Nathan
    Abiko, Kaoru
    Baba, Tsukasa
    Yamaguchi, Ken
    Murakami, Ryusuke
    Hosoe, Yuko
    Azuma, Miyuki
    Konishi, Ikuo
    Mandai, Masaki
    CANCER SCIENCE, 2018, 109 : 1323 - 1323
  • [26] VISTA expressed in tumour cells regulates T cell function
    Mulati, Kumuluzi
    Hamanishi, Junzo
    Matsumura, Noriomi
    Chamoto, Kenji
    Mise, Nathan
    Abiko, Kaoru
    Baba, Tsukasa
    Yamaguchi, Ken
    Horikawa, Naoki
    Murakami, Ryusuke
    Taki, Mana
    Budiman, Kharma
    Zeng, Xiang
    Hosoe, Yuko
    Azuma, Miyuki
    Konishi, Ikuo
    Mandai, Masaki
    BRITISH JOURNAL OF CANCER, 2019, 120 (01) : 115 - 127
  • [27] VISTA expressed in tumour cells regulates T cell function
    Kumuluzi Mulati
    Junzo Hamanishi
    Noriomi Matsumura
    Kenji Chamoto
    Nathan Mise
    Kaoru Abiko
    Tsukasa Baba
    Ken Yamaguchi
    Naoki Horikawa
    Ryusuke Murakami
    Mana Taki
    Kharma Budiman
    Xiang Zeng
    Yuko Hosoe
    Miyuki Azuma
    Ikuo Konishi
    Masaki Mandai
    British Journal of Cancer, 2019, 120 : 115 - 127
  • [28] PD-L2 is a second ligand for PD-1 and inhibits T cell activation
    Yvette Latchman
    Clive R. Wood
    Tatyana Chernova
    Divya Chaudhary
    Madhuri Borde
    Irene Chernova
    Yoshiko Iwai
    Andrew J. Long
    Julia A. Brown
    Raquel Nunes
    Edward A. Greenfield
    Karen Bourque
    Vassiliki A. Boussiotis
    Laura L. Carter
    Beatriz M. Carreno
    Nelly Malenkovich
    Hiroyuki Nishimura
    Taku Okazaki
    Tasuku Honjo
    Arlene H. Sharpe
    Gordon J. Freeman
    Nature Immunology, 2001, 2 : 261 - 268
  • [29] RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
    Xiao, Yanping
    Yu, Sanhong
    Zhu, Baogong
    Bedoret, Denis
    Bu, Xia
    Francisco, Loise
    Hua, Ping
    Duke-Cohan, Jonathan
    Umetsu, Dale
    Sharpe, Arlene
    DeKruyff, Rosemarie
    Freeman, Gordon
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [30] RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory tolerance
    Xiao, Yanping
    Yu, Sanhong
    Zhu, Baogong
    Bedoret, Denis
    Bu, Xia
    Francisco, Loise M.
    Hua, Ping
    Duke-Cohan, Jonathan S.
    Umetsu, Dale T.
    Sharpe, Arlene H.
    DeKruyff, Rosemarie H.
    Freeman, Gordon J.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (05): : 943 - 959